Nordisk Selskab for Gynækologisk Onkologis Kliniske Forskningsfond — Credit Rating and Financial Key Figures
CVR number: 30197372
Blegdamsvej 9, 2100 København Ø
adela.ioana.buda@regionh.dk
tel: 35453389
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 4 524.46 | 4 563.51 | 7 416.45 | 7 068.56 | 7 031.63 |
| Employee benefit expenses | -4 823.22 | -5 058.74 | -6 083.19 | -6 367.88 | -6 645.86 |
| EBIT | - 298.76 | - 495.24 | 1 333.27 | 700.69 | 385.76 |
| Other financial income | 106.45 | 66.79 | 55.66 | 386.81 | 1 122.95 |
| Other financial expenses | -45.51 | - 202.98 | - 922.04 | -1.36 | -99.96 |
| Pre-tax profit | - 237.81 | - 631.43 | 466.89 | 1 086.13 | 1 408.74 |
| Net earnings | - 237.81 | - 631.43 | 466.89 | 1 086.13 | 1 408.74 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Other receivables | -10 890.57 | ||||
| Investments total | -10 890.57 | ||||
| Non-current loans receivable | 10 890.57 | ||||
| Long term receivables total | 10 890.57 | ||||
| Inventories total | |||||
| Current trade debtors | 60.42 | 310.26 | 20.75 | 5 243.61 | 424.61 |
| Prepayments and accrued income | 1 742.98 | 2 719.69 | 5 515.64 | 7 388.99 | 279.47 |
| Current other receivables | 1 642.29 | 11 587.03 | 1 808.54 | 566.38 | 506.01 |
| Short term receivables total | 3 445.69 | 14 616.98 | 7 344.93 | 13 198.98 | 1 210.09 |
| Other current investments | 11 057.53 | 10 051.29 | 10 318.44 | 10 859.40 | |
| Cash and bank deposits | 3 965.84 | 8 749.72 | 8 243.67 | 4 746.54 | 14 411.00 |
| Cash and cash equivalents | 15 023.37 | 8 749.72 | 18 294.96 | 15 064.97 | 25 270.41 |
| Balance sheet total (assets) | 18 469.06 | 23 366.70 | 25 639.89 | 28 263.95 | 26 480.50 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 |
| Retained earnings | 2 848.59 | 2 610.78 | 1 979.35 | 2 446.24 | 3 532.36 |
| Profit of the financial year | - 237.81 | - 631.43 | 466.89 | 1 086.13 | 1 408.74 |
| Shareholders equity total | 2 910.78 | 2 279.35 | 2 746.24 | 3 832.36 | 5 241.11 |
| Provisions | 2 089.85 | 1 962.52 | 3 967.51 | ||
| Non-current liabilities total | |||||
| Current trade creditors | 107.08 | 482.14 | 102.68 | 516.94 | 247.42 |
| Other non-interest bearing current liabilities | 50.00 | 350.00 | 50.00 | 292.66 | 1 636.33 |
| Accruals and deferred income | 15 401.20 | 20 255.21 | 20 651.13 | 21 659.46 | 15 388.14 |
| Current liabilities total | 15 558.28 | 21 087.35 | 20 803.81 | 22 469.06 | 17 271.88 |
| Balance sheet total (liabilities) | 18 469.06 | 23 366.70 | 25 639.89 | 28 263.95 | 26 480.50 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.